| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,724 |
17,588 |
$1.24M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,163 |
4,069 |
$317K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,540 |
3,455 |
$271K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,859 |
2,777 |
$236K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,403 |
2,183 |
$171K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,700 |
1,516 |
$138K |
| 92551 |
|
8,028 |
7,839 |
$77K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,067 |
1,966 |
$69K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,708 |
5,845 |
$61K |
| 90651 |
|
1,363 |
1,326 |
$53K |
| 90670 |
|
1,691 |
1,635 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,746 |
2,578 |
$35K |
| 90686 |
|
2,521 |
2,430 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,954 |
927 |
$26K |
| 81002 |
|
7,980 |
7,513 |
$22K |
| 90680 |
|
1,283 |
1,224 |
$21K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
575 |
536 |
$20K |
| 99173 |
|
8,120 |
7,928 |
$19K |
| 90619 |
|
400 |
391 |
$16K |
| 96127 |
|
3,281 |
3,195 |
$15K |
| 90734 |
|
489 |
482 |
$15K |
| 90633 |
|
1,159 |
1,133 |
$15K |
| 90710 |
|
598 |
592 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
821 |
784 |
$13K |
| 90698 |
|
777 |
742 |
$13K |
| 90677 |
|
260 |
224 |
$12K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
122 |
120 |
$10K |
| 0072A |
|
171 |
170 |
$7K |
| 0071A |
|
168 |
167 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
500 |
429 |
$5K |
| 90647 |
|
353 |
344 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
131 |
128 |
$4K |
| 90715 |
|
236 |
229 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
465 |
342 |
$4K |
| 90744 |
|
259 |
247 |
$3K |
| 90672 |
|
117 |
99 |
$2K |
| 90621 |
|
51 |
47 |
$2K |
| 87428 |
|
77 |
75 |
$2K |
| 90656 |
|
148 |
148 |
$2K |
| 99174 |
|
439 |
426 |
$2K |
| 90700 |
|
161 |
154 |
$2K |
| 90620 |
|
73 |
69 |
$2K |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
144 |
128 |
$2K |
| 0001A |
|
38 |
37 |
$1K |
| 90696 |
|
69 |
66 |
$1K |
| A7006 |
Administration set, with small volume filtered pneumatic nebulizer |
195 |
171 |
$944.26 |
| 0002A |
|
21 |
21 |
$840.00 |
| 99000 |
|
256 |
249 |
$706.56 |
| 96161 |
|
542 |
424 |
$584.73 |
| 94760 |
|
406 |
340 |
$533.69 |
| 87807 |
|
36 |
31 |
$408.08 |
| 99050 |
|
32 |
32 |
$374.13 |
| 99188 |
|
13 |
13 |
$270.27 |
| 90723 |
|
15 |
15 |
$244.04 |
| 97802 |
|
138 |
138 |
$183.72 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
45 |
37 |
$161.10 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
86 |
81 |
$117.89 |
| A7015 |
Aerosol mask, used with dme nebulizer |
111 |
99 |
$110.57 |
| 99051 |
|
65 |
62 |
$88.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
369 |
314 |
$14.46 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
97 |
85 |
$12.45 |
| 91307 |
|
393 |
332 |
$2.56 |
| 91300 |
|
70 |
50 |
$0.43 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,095 |
1,066 |
$0.00 |
| 99072 |
|
47 |
46 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
14 |
13 |
$0.00 |